Discovery of renin inhibitors containing a simple aspartate binding moiety that imparts reduced P450 inhibition

Bioorg Med Chem Lett. 2017 Nov 1;27(21):4838-4843. doi: 10.1016/j.bmcl.2017.09.046. Epub 2017 Sep 23.

Abstract

Discovery of potent renin inhibitors which contain a simplified alkylamino Asp-binding group and exhibit improved selectivity for renin over Cyp3A4 is described. Structure-function results in this series are rationalized based on analysis of selected compounds bound to renin, and the contribution of each molecular feature leading to the reduced P450 inhibition is quantified.

Keywords: Biphenyl; Cyp3A4; Hypertension; Renin inhibitors; X-ray crystallography.

MeSH terms

  • Aspartic Acid / chemistry
  • Aspartic Acid / metabolism*
  • Binding Sites
  • Crystallography, X-Ray
  • Cytochrome P-450 CYP3A / chemistry
  • Cytochrome P-450 CYP3A / metabolism*
  • Cytochrome P-450 CYP3A Inhibitors / chemistry
  • Cytochrome P-450 CYP3A Inhibitors / metabolism
  • Drug Evaluation, Preclinical
  • Humans
  • Inhibitory Concentration 50
  • Molecular Dynamics Simulation
  • Protease Inhibitors / chemistry*
  • Protease Inhibitors / metabolism
  • Protein Binding
  • Renin / antagonists & inhibitors*
  • Renin / metabolism
  • Structure-Activity Relationship

Substances

  • Cytochrome P-450 CYP3A Inhibitors
  • Protease Inhibitors
  • Aspartic Acid
  • Cytochrome P-450 CYP3A
  • Renin